PMID- 34291477
OWN - NLM
STAT- MEDLINE
DCOM- 20220110
LR  - 20221207
IS  - 1365-2230 (Electronic)
IS  - 0307-6938 (Print)
IS  - 0307-6938 (Linking)
VI  - 47
IP  - 1
DP  - 2022 Jan
TI  - Induction and exacerbation of subacute cutaneous lupus erythematosus following 
      mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.
PG  - 161-163
LID - 10.1111/ced.14858 [doi]
AB  - Evidence is accumulating that COVID-19 vaccines might induce or exacerbate 
      autoimmune rheumatic diseases. The currently available COVID-19 vaccines include 
      mRNA and recombinant adenoviral vector vaccines, both encoding SARS-CoV-2 spike 
      protein production as the primary target for neutralizing antibodies. We report a 
      case of subacute cutaneous lupus erythematosus (SCLE) following mRNA vaccination 
      with the Pfizer mRNA vaccine BNT162b2, and summarize the current literature on 
      CLE occurring after COVID-19 vaccination.
CI  - (c) 2021 British Association of Dermatologists.
FAU - Kreuter, A
AU  - Kreuter A
AUID- ORCID: 0000-0003-2275-499X
AD  - Department of Dermatology, Venereology and Allergology, HELIOS St Elisabeth 
      Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
FAU - Licciardi-Fernandez, M J
AU  - Licciardi-Fernandez MJ
AD  - Department of Dermatology, Venereology and Allergology, HELIOS St Elisabeth 
      Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
FAU - Burmann, S-N
AU  - Burmann SN
AD  - Department of Dermatology, Venereology and Allergology, HELIOS St Elisabeth 
      Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
FAU - Burkert, B
AU  - Burkert B
AD  - Department of Dermatology, Venereology and Allergology, HELIOS St Elisabeth 
      Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
FAU - Oellig, F
AU  - Oellig F
AD  - Institute of Pathology, Mulheim an der Ruhr, Germany.
FAU - Michalowitz, A-L
AU  - Michalowitz AL
AD  - Department of Dermatology, Venereology and Allergology, HELIOS St Elisabeth 
      Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
LA  - eng
PT  - Case Reports
PT  - Letter
PT  - Review
DEP - 20210913
PL  - England
TA  - Clin Exp Dermatol
JT  - Clinical and experimental dermatology
JID - 7606847
RN  - JT2NS6183B (Ad26COVS1)
RN  - B5S3K2V0G8 (ChAdOx1 nCoV-19)
RN  - N38TVC63NU (BNT162 Vaccine)
SB  - IM
MH  - Ad26COVS1/adverse effects
MH  - Aged
MH  - BNT162 Vaccine/*adverse effects
MH  - COVID-19/*prevention & control
MH  - ChAdOx1 nCoV-19/adverse effects
MH  - Drug Eruptions/*etiology
MH  - Humans
MH  - Lupus Erythematosus, Cutaneous/*chemically induced
MH  - Male
MH  - SARS-CoV-2
MH  - Vaccination/adverse effects
PMC - PMC8444843
EDAT- 2021/07/23 06:00
MHDA- 2022/01/11 06:00
PMCR- 2021/09/13
CRDT- 2021/07/22 06:50
PHST- 2021/07/19 00:00 [revised]
PHST- 2021/07/15 00:00 [received]
PHST- 2021/07/20 00:00 [accepted]
PHST- 2021/07/23 06:00 [pubmed]
PHST- 2022/01/11 06:00 [medline]
PHST- 2021/07/22 06:50 [entrez]
PHST- 2021/09/13 00:00 [pmc-release]
AID - CED14858 [pii]
AID - 10.1111/ced.14858 [doi]
PST - ppublish
SO  - Clin Exp Dermatol. 2022 Jan;47(1):161-163. doi: 10.1111/ced.14858. Epub 2021 Sep 
      13.